Detection of donor-specific hyporesponsiveness following late failure of human renal allografts

Kidney International

Volumn 50, Issue 3, 1996, Pages 1019-1025

  Mason, Philip D ^a,b   Robinson, Catherine M ^a   Lechler, Robert I ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ARTICLE; CLINICAL ARTICLE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029785349     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.404     Document Type: Article

References (23)

1. HALL BM, DORSCH SE: Cells mediating allograft rejection. Immunol Rev 77:31-59, 1984
2. BISHOP KD, OROSZ CG: Limiting dilution analysis for alloreactive, TCGF-secretory T cells. Transplantation 47:671-677, 1989
3. DEACOCK S, SCHWARER A, BATCHELOR R, GOLDMAN J, LHCHLER R: A rapid limiting dilution assay for measuring frequencies of alloreactive, interleukin-2-producing T cells in humans. J Immunol Meth 147:83-92, 1992
4. BISHOP KD, FERGUSON RM, OROSZ CG: Differential distribution of antigen-specific helper T cells after antigenic stimulation in vivo. J Immunol 144:1153-1161, 1990
5. DEACOCK SJ, LECHLER RI: Positive correlation of T cell sensitisation with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 54:338-343, 1992
6. MASON PD, ROBINSON CR, DEACOCK SJ, LECHLER RI: Tolerance versus sensitisation against donor HLA-DR antigens in patients on dialysis following renal transplant failure. (abstract) QJ Med 87:582-583, 1994
7. SCHWARER AP, JIANG YZ, BROOKLS PA, BARRETT AJ, BATCHELOR JR, GOLDMAN JM, LECHLER RI: Frequency of anti-recipient helper T cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Lancet 341:203-205, 1993
8. YOUNG YANG S, MILFORD E, HÄMMERLING U, DUPONT B: Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: The B cell line panel designated for the Tenth International Histocompatibility Workshop, in Immunobiology of HLATenth International Histocompatibility Workshop, edited by DUPONT B, New York, Springer-Verlag, 1989. p 11
9. LOMBARDI G, SIDHU S, LAMB JR, BATCHELOR JR, LECHLER-RI: Co-recognition of endogenous antigens with HLA-DR1 by alloreactive human T cell clones. J Immunol 142:753-759, 1989
10. FAZEKAS DE ST GROTH S; The evaluation of limiting dilution assays. J Immunol Meth 49:R11-R23, 1982
11. HOSTETTER TH: Chronic transplant rejection. (Editorial Review) Kidney Int 46:266-79, 1994
12. QUILL H, SCHWARTZ RH: Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative non responsiveness. (abstract) J Immunol 138:3704, 1987
13. JENKINS MK, PARDOLL DM, MIZUGUCHI J, CHUSED TM, SCHWARTZ RH: Molecular events in the induction of non responsive state in interleukin 2-producing helper T-lymphocyte clones. (abstract) Proc Natl Acad Sci USA 84:5409, 1987
14. BRAUN MY, MCCORMACK A, WEBB G, BATCHELOR JR: Evidence for clonal anergy as a mechanism for the maintenance of transplantation tolerance. Eur J Immunol 23:1462-1468, 1993
15. LECHLER RI, BATCHELOR JR: Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 155:31-41, 1982
16. SINGER A, MUNITZ TI, GOLDING H, ROSENBERG AS, MIZOUCH T: Recognition requirements for the activation, differentiation and function of T helper cells specific for class I MHC alloantigens. Immunol Rev 98:143-170, 1987
17. PARKER KE, DALCHAU R, FOWLER VJ, PRIESTLEY CA, CARTER CA, FABRE JW: Stimulation of CD4+ T lymphocytes by allogeneic MHC peptides presented on autologous antigen-presenting cells. Transplantation 53:918-921, 1992
18. PRIESTLEY CA, SPENCER SC, SAWYER GJ, FABRE JW: Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class II MHC antigens. Transplantation 53:1024-1032, 1992
19. MALUK SC, CLERICI M, VIA CS, WIER MR, KIMMEL PL, SHEARER GM: Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients. Transplantation 52:284-291, 1991
20. ROOLEN D, DATEMA G, VAN BREE S, ZHANG L, VAN ROOD J, CLAAS F: Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen. Transplantation 53:899-903, 1992
21. LUBAROFF DM, SILVERS WK: Importance of chimerism in maintaining tolerance of skin allografts in mice. J Immunol 111:65, 1973
22. GRAY D, MATZINGER P: T cell memory is short-lived in the absence of antigen. J Exp Med 174:969-974, 1991
23. STARZL T, DEMETRIS AJ, TRUCCO M, ZEEVI A, RAMOS H, TERASAKI P, RUDERT WA, KOCOVA M, RICORDI C, IILSTAD S, MURASE N: Chimerism and donor-specific non reactivity 27 to 29 years after kidney allotransplantation. Transplantation 55:1272-1277, 1993